logo

For the Inventor, By the Inventor

Miami, FL, United States of America

Coulter Corporation


USPTO Granted Patents = 99

Trademarks = 6

Forward Citations = 3,032

Loading Chart...
Loading Chart...

104 inventors (with patents filed for the assignee):

goldMedal Olavi Siiman (14 out of 24 patents)

silverMedal Thomas R Russell (14 out of 19 patents)

bronzeMedal Kenneth H Kortright (13 out of 13 patents)

4.  Wallace H Coulter (10 out of 32 patents)

5.  Alexander Burshteyn (9 out of 17 patents)

6.  Carlos M Rodriguez (9 out of 20 patents)

7.  Ravinder K Gupta (9 out of 16 patents)

8.  Timothy J Fischer (8 out of 40 patents)

9.  John A Maples (7 out of 15 patents)

10.  Ronald D Paul (7 out of 9 patents)

11.  Carole Jo Young (7 out of 18 patents)

12.  David E Hofheinz (7 out of 7 patents)

13.  John D Hollinger (6 out of 8 patents)

14.  James H Carter (6 out of 7 patents)

15.  Frank J Lucas (5 out of 12 patents)


Core Competencies:
Hematological Analysis
Monoclonal Antibodies
Cell Screening
Enzyme Activity Determination
Control Cell Preparation
Leukocyte Differentiation
T-Cell Induction
Optical Screening
Particle Sizing
Fluid Sample Analysis
Biodegradable Coatings
Automated Cell Enumeration

99 patents:

1. 6362003 - Hematological reference control composition containing leukocyte analogs, methods of making, and uses thereof (2002-03-26),
2. 6281335 - Hybridoma and anti-KC-4 humanized monoclonal antibody (2001-08-28),
3. 6159740 - Method and apparatus for screening obscured or partially obscured cells (2000-12-12),
4. 5871946 - Method for determining activity of enzymes in metabolically active whole (1999-02-16),
5. 5861311 - Preserved, non-infectious control cells prepared by the modulation or (1999-01-19),
6. 5849513 - Assay reagent (1998-12-15),
7. 5834315 - Cyanide-free reagent and method for hemoglobin determination and (1998-11-10),
8. 5798217 - Method of analyzing tumor cell DNA content through tumor cell enrichment (1998-08-25),
9. 5786224 - Reagent and method for differential determination of leukocytes in blood (1998-07-28),
10. 5783673 - Method of preferential labelling of a phycobiliprotein with an (1998-07-21),
11. 5776720 - Assay reagent (1998-07-07),
12. 5776706 - Polymeric particles having a biodegradable gelatin or aminodextran (1998-07-07),
13. 5763204 - Preparation of preserved, non-infectious control cell for use in the (1998-06-09),
14. 5733719 - Method of making an assay compound (1998-03-31),
15. 5707877 - Biodegradable gelatin-aminodextran particle coatings of and processes (1998-01-13),
Coulter Corporation is a leading global provider of innovative solutions for the healthcare industry. With over 50 years of experience, we specialize in the development and manufacturing of cutting-edge medical equipment and diagnostic systems. Our mission is to improve patient care by delivering reliable, accurate, and efficient diagnostic solutions. Our products range from advanced blood analyzers to digital imaging systems, serving various medical disciplines such as hematology, oncology, and microbiology. We are committed to continuous innovation, rigorous quality control, and exceptional customer support.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

99 Patents

#7 in Miami, FL

#87 in Florida

#3,690 in US

#7,627 in the World

...
Miami, FL, United States of America

Coulter Corporation

Forward Citations = 3,032

104 inventors:

goldMedal Olavi Siiman (14 out of 24 patents)

silverMedal Thomas R Russell (14 out of 19 patents)

bronzeMedal Kenneth H Kortright (13 out of 13 patents)

4.  Wallace H Coulter (10 out of 32 patents)

5.  Alexander Burshteyn (9 out of 17 patents)

Please report any incorrect information to support@idiyas.com
Loading…